The Future of Pharma: The Scale to Fail
This article was originally published in RPM Report
Executive Summary
The pharmaceutical sector saw a wave of major consolidation in 2009. There are a number of lessons to be learned from the M&A activity that can be applied to the New Year, including the increasing need to get bigger in order to absorb the R&D misses.